Shkreli charges prompt Nasdaq to delist KaloBios

Martin Shkreli has already been ousted as CEO of KaloBios ($KBIO). And now, Nasdaq plans to delist the company, citing Shkreli's recent arrest on fraud and looting charges as one reason for the move. More from FierceBiotech